CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Reserve excluding Revaluation Reserve History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Reserve excluding Revaluation Reserve | ₹686 Cr | ₹545 Cr | ₹419 Cr | ₹347 Cr |
What is the latest Reserve excluding Revaluation Reserve ratio of CORONA REMEDIES ?
| Year | Reserve excluding Revaluation Reserve |
|---|---|
| Mar2026 | ₹686 Cr |
| Mar2025 | ₹545 Cr |
| Mar2024 | ₹419 Cr |
| Mar2023 | ₹347 Cr |
How is Reserve excluding Revaluation Reserve of CORONA REMEDIES Trending?
| Years | Reserve excluding Revaluation Reserve | % Change | |
|---|---|---|---|
| Mar2026 | ₹686 Cr | 25.77 | |
| Mar2025 | ₹545 Cr | 30.04 | |
| Mar2024 | ₹419 Cr | 20.70 | |
| Mar2023 | ₹347 Cr | - | |
Compare Reserve excluding Revaluation Reserve of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,326.6 Cr | -1.2% | -8% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,707.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -1.2% |
-8% |
|
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses